돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 434807생성일: 2026년 10월 26일

1-Butanol → 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-propyl-, (S)-

https://huagongshe.com/reaction/434807

반응식

참여 물질

역할이름HCID투입량
반응물1-ButanolHCID 263—
반응물Hydrogen PeroxideHCID 784—
반응물Sulfuric AcidHCID 1118—
반응물CamptothecinHCID 24360—
용매WaterHCID 962—
생성물1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-propyl-, (S)-HCID 149612—

반응 단계

Ferrous sulfate heptahydrate (2.8 g, 10.1 m-mol) and 1-butanol (3 ml, 43 m-mol) were dissolved in water (30 ml). Camptothecin (500 mg, 1.43 m-mol) was suspended in the solution and dissolved therein by addition of concentrated sulfuric acid (15 ml). To this solution was added dropwise under ice-cooling and agitation a 30% aqueous solution of hydrogen peroxide (1.1 ml, 10.1 m-mol) in small portions. The agitation was continued for 4 hours at room temperature. The reaction mixture was diluted with ice water (1.5 l) and extracted with chloroform (2 l). The chloroform layer was dried with magnesium sulfate, filtered and evaporated until dryness under reduced pressure. The residue was subjected to column chromatography (chloroform) through silica gel (15 g) to effect separation and purification of the product which was then recrystallized from n-hexane-chloroform whereby 110 mg (21.0%) of the objective compound were obtained as light yellow white needle crystals. M.P. 260°-261° C.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04399282
출처 데이터셋uspto-grants-1983_08
ORD IDord-1cba03a8182a498b870e58f1728a2231
출처 메모uspto-grants-1983_08